[
  {
    "criterion": "Provides overly technical medical jargon without seeking clarification from the user",
    "axis": "communication_quality",
    "point": -5
  },
  {
    "criterion": "Falsely claims that rifaximin is always effective in reducing ammonia levels",
    "axis": "accuracy",
    "point": -9
  },
  {
    "criterion": "Asks the user to clarify their query before providing any medical information",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Provides a detailed explanation of the treatment options for hepatic encephalopathy",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Correctly indicates that lactulose dosing should be adjusted based on the patient's ammonia level",
    "axis": "accuracy",
    "point": 5
  },
  {
    "criterion": "Provides a clear and concise summary of the medical information",
    "axis": "communication_quality",
    "point": 6
  },
  {
    "criterion": "Does not mention the potential side effects of rifaximin",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "Fails to consider the patient's stage of hepatic encephalopathy when recommending treatment",
    "axis": "accuracy",
    "point": -7
  },
  {
    "criterion": "Provides personalized medical advice without considering the user's specific situation",
    "axis": "context_awareness",
    "point": -5
  },
  {
    "criterion": "Clearly explains the importance of monitoring the patient's ammonia levels",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Falsely claims that rifaximin is only used as a treatment for stage 3 or more advanced hepatic encephalopathy",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Does not provide any medical information",
    "axis": "completeness",
    "point": -10
  }
]